Clinical trial
Weekly Topotecan in Patients Treated for Metastatic Colorectal Cancer
NCT00193167 · SCRI Development Innovations, LLC, Other · Completed
Key facts
| NCT number | NCT00193167 |
|---|---|
| Title | Weekly Topotecan in Patients Treated for Metastatic Colorectal Cancer |
| Official title | Phase II Study of Weekly Topotecan in Patients Treated for Metastatic Colorectal Cancer |
| Lead sponsor | SCRI Development Innovations, LLC, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colon Cancer |
| Intervention type | Drug |
| Interventions | Topotecan |
| Enrollment | 40 |
| Start date | Jan 1, 2004 |
| Primary completion | Apr 1, 2006 |
| Completion | Apr 1, 2006 |
| First posted | Sep 19, 2005 |
| Last update posted | May 3, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: